Institutional | PRESS ROOM | INIBSA

WE ARE INIBSA
BACK
WE ARE INIBSA
- PRESENTATION
- HISTORY
- INNOVATION
- ESG
PRODUCTS
BACK
PRODUCTS
- Pain control
  PRODUCTS
  Pain control
  - Local anaesthesics
    
    Pain control
    Local anaesthesics
    
    Injectable anaesthetics
    
    Local anaesthesics
    Injectable anaesthetics
    
    Artinibsa 4% 1:100,000 solution for injection
    
    Artinibsa 4% 1:200,000 solution for injection
    
    Xilonibsa 2% 1:80,000 solution for injection
    
    Scandinibsa 3% solution for injection
    
    Scandinibsa 2% 1:100,000 solution for injection
    
    Inibsacain 0.5% 1:200,000 solution for injection
    
    Ver todos los productos
    
    Topical anaesthetics
    
    Local anaesthesics
    Topical anaesthetics
    
    Xilonibsa spray 10%
    
    Ver todos los productos
    
    View all products
  - Dental needles
    
    Pain control
    Dental needles
    
    MONOPROTECT^® INIBSA
    
    MONOPROTECT^® Inibsa PLUS
  - Dental syringes
    
    Pain control
    Dental syringes
    
    Prestoject^® CW
    
    Prestoject^® HK
    
    Prestoject^® FL
    
    Prestoject^® IL
    
    Prestoject^® Safety stand
  - View all products
- View all products
GLOBAL PRESENCE
BLOG

Inibsa — Institutional

Inibsa group accelerates its development with the support of Septodont and Acteon as…

04/09/2024

As a majority shareholder, Septodont will acquire a controlling stake in Inibsa alongside Acteon as…

Inibsa